Generic Overview of Healthcare Cost‑Reduction Policies and Value‑Based Medicine

Generic Overview of Healthcare Cost‑Reduction Policies and Value‑Based Medicine The passage merely outlines policy objectives, waste estimates, and market opportunities without naming specific actors, transactions, or actionable leads. It offers no novel or sensitive information linking powerful individuals or entities to misconduct. Key insights: Estimates $765 billion annual waste in U.S. healthcare, $415 billion from fraud and inefficiency.; Calls for shift to value‑based medicine and outcome‑based reimbursement.; Highlights market opportunity for technology‑focused companies in efficiency tools.